Czech National Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$80.1M Buy
431,771
+26,296
+6% +$4.88M 0.62% 23
2025
Q1
$85M Buy
405,475
+22,324
+6% +$4.68M 0.78% 22
2024
Q4
$68.1M Buy
383,151
+23,328
+6% +$4.15M 0.63% 24
2024
Q3
$71.1M Buy
359,823
+23,320
+7% +$4.61M 0.72% 22
2024
Q2
$57.7M Buy
336,503
+25,855
+8% +$4.43M 0.66% 22
2024
Q1
$56.6M Buy
310,648
+1,373
+0.4% +$250K 0.73% 22
2023
Q4
$47.9M Buy
309,275
+780
+0.3% +$121K 0.68% 22
2023
Q3
$46M Buy
308,495
+99,639
+48% +$14.9M 0.73% 21
2023
Q2
$28.1M Buy
208,856
+520
+0.2% +$70.1K 0.64% 24
2023
Q1
$33.2M Buy
208,336
+1,238
+0.6% +$197K 0.82% 19
2022
Q4
$33.5M Buy
207,098
+1,714
+0.8% +$277K 0.89% 20
2022
Q3
$27.6M Buy
+205,384
New +$27.6M 0.79% 21